Prevention of interleukin-2-induced severe bronchospasm with salbutamol.
Barutca
Sabri
S
Meydan
Nezih
N
Barlak
Ahmet
A
D000280:Administration, Inhalation; D000336:Aerosols; D000420:Albuterol / Q000627:therapeutic use*; D001986:Bronchial Spasm / Q000139:chemically induced / Q000517:prevention & control*; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D002292:Carcinoma, Renal Cell / Q000188:drug therapy; D006801:Humans; D007376:Interleukin-2 / Q000009:adverse effects* / Q000627:therapeutic use; D007680:Kidney Neoplasms / Q000188:drug therapy; D008297:Male; D008875:Middle Aged
D000336:Aerosols; D001993:Bronchodilator Agents; D007376:Interleukin-2; D000420:Albuterol